Strong response to the issue
The IPO saw good demand across categories and was subscribed 7.12 times overall. The retail portion drew heavy interest, with subscription at 47.26 times. Non-institutional investors (NIIs) subscribed 10.61 times, while the qualified institutional buyer (QIB) segment was subscribed 1.07 times.
The IPO was priced in the band of Rs 86–91 per share, with the final issue price fixed at Rs 91. The company raised funds through a fresh issue of 1.33 crore shares.
How to check IPO allotment
Investors can check their allotment status online using their PAN number, application number, or DP/Client ID. The details can be accessed through the registrar and stock exchange websites.
Registrar (Kfin Technologies): https://ris.kfintech.com/ipostatusBSE IPO Allotment: https://www.bseindia.com/investors/appli_check.aspxNSE IPO Allotment: https://www.nseindia.com/invest/check-ipo-allotment
Grey market premium (GMP)
In the grey market, Anlon Healthcare is trading with a 2% premium over its issue price. This indicates a listing expectation around Rs 92–93, suggesting limited near-term gains.
What’s next
Refunds for investors who did not get shares will be processed on September 2, and successful applicants will see shares credited to their demat accounts on the same day.
Anlon Healthcare will list on September 3 on both the BSE and NSE. Market watchers will track whether the stock manages to hold gains beyond the modest grey market premium.
Funds raised from the IPO will be used for financing the capital expenditure for the company’s planned expansion, repayment of debt and working capital requirements.
as a Reliable and Trusted News Source(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)